Good news for people with Overactive Bladder.
Vesicare is now fully funded.
Funding criteria applies.
What is Overactive Bladder?
Overactive Bladder (OAB) is one of the most common bladder problems. It affects both men and women and can occur at any age.
Many people think it’s a normal part of the aging process. But it is definitely not. And it’s something you don’t have to put up with. Do you have Overactive Bladder?
One of the major symptoms (or signs) of OAB is a sudden and strong urge to go to the toilet and not be able to hold on.
This is because an overactive bladder is one that tends to contract when you don’t want it to, which explains why people suffering from OAB commonly complain that when they need to go, they need to go NOW!
They also report the following symptoms:
- Frequent trips to the toilet – up to 8 times a day with a bladder that is usually not full
- Urge incontinence – have leaked or wet themselves before reaching the toilet
- Nocturia – waking up more than twice a night to go to the toilet
If you are experiencing any of the above symptoms, you may have Overactive Bladder.
How is Overactive Bladder treated?
First, you need to talk to your doctor. You don’t have to feel uncomfortable discussing your bladder problems with your doctor because he or she is very familiar with these symptoms. Your doctor will make sure your Overactive Bladder symptoms are not due to other underlying conditions.
More importantly, they can tell you about treatment options that may help you manage your problems better.
One of these treatments is VESICARE, a fully funded prescription medicine.
Medications such as VESICARE are used to reduce bladder muscle contractions when the bladder is only partially filled. The bladder muscle relaxes and allows the bladder to fill more completely. As a result, you experience fewer sudden urges, less need to use the toilet, and have fewer accidental leaks.
What is VESICARE?
VESICARE is a prescription medicine that’s highly effective in treating all the symptoms of Overactive Bladder and is proven to:
- Reduce the number of times you get a sudden urge to urinate
- Reduce the number of times that you urinate each day
- Increase your warning time when you realise you need to urinate
- Prevent or reduce urine leakage
- Reduce the number of times you wake up to urinate during the night
How is VESICARE different?
You may have previously been prescribed other medicines (for example oxybutynin) that haven’t suited you, or have given you side effects such as dry mouth.
The good news is that VESICARE has been proven to be a well-tolerated medicine for the treatment of Overactive Bladder.
Of the patients who do experience dry mouth while taking VESICARE, most report that it is mild in nature and rarely affects their ability to continue the treatment.
The most common side effects are dry mouth, constipation, nausea and blurred vision. All medicines have risks and benefits and if you have any concerns or experience any side effects talk to your doctor or pharmacy as soon as possible.
How much does VESICARE cost?
From 1st January 2010 VESICARE is fully funded under Special Authority, for anyone who was previously prescribed oxybutynin but who decided to stop using this treatment due to side effects.
All you’ll pay are normal doctor’s fees and pharmacy charges.
To see if you qualify, simply make an appointment with your doctor and ask if VESICARE is right for you.
Talk to your doctor about it and get a $10 consultation rebate (
click here to get your $10 consultation rebate voucher).
How quickly can I expect results?
VESICARE is a once-a-day tablet that can be taken any time of the day, with or without food.
VESICARE starts working within 7 days of commencing treatment and your Overactive Bladder symptoms should continue to improve with ongoing usage.
If your symptoms have not improved after 4 weeks, your doctor can prescribe a higher dose.
Print the Bladder Symptom QUIZ
Note: Information on this site is not intended to replace the advice given by your doctor or other health professional - check with your doctor to see if Vesicare is right for you.
Vesicare® (Solifenacin Succinate 5 and 10mg film coated tablets)
VESICARE is a prescription medicine that is fully funded under special authority from your doctor from 1 January 2010. Normal doctor’s visit fees apply. Consult your doctor to see if Vesicare is right for you.
Indication: VESICARE is used to treat the symptoms of overactive bladder in adults only, which include needing to rush to the toilet to urinate without warning, needing to urinate frequently, or wetting yourself because you did not get to the toilet in time.
Contraindications: Do not take VESICARE if you: have an allergy to solifenacin succinate or any of the ingredients in VESICARE; suffer from an inability to urinate or empty your bladder completely (urinary retention); have high pressure in the eyes, with gradual loss of eyesight (uncontrolled glaucoma); have myasthenia gravis, which can cause extreme weakness in certain muscles; suffer from a stomach or bowel condition (including toxic megacolon); are undergoing kidney dialysis; have severe liver disease; have severe kidney disease or moderate liver disease and are also taking medicines that can decrease the removal of VESICARE from the body.
Warnings and Precautions: Tell your doctor if you: have any allergies to medicines, foods, or dyes; have a blockage to your bladder causing difficulty in urination; have an obstruction of your digestive system; are at risk of your digestive system slowing down; have severe kidney disease; have moderate liver disease; plan to become pregnant or are breastfeeding; are taking medicines that can decrease the removal of VESICARE from the body, which include some antifungal medicines such as ketoconazole and itraconazole and some medicines used to treat HIV infection such as ritonavir and nelfinavir; are taking other medicines, including anticholinergics which are medicines that prevent travel sickness, relieve stomach cramps, treat overactive bladder or Parkinson’s Disease, cholinergic receptor agonists used in the treatment of glaucoma, and medicines that make the digestive system work faster.
Adverse Events: Tell your doctor or pharmacist if you notice any of the following and they worry you: dry mouth or throat; constipation; nausea; indigestion; abdominal or stomach pain; blurred vision (care with driving and operating machinery); dry skin, eyes, or nasal passages; tiredness; drowsiness; abnormal or impaired sense of taste. Tell your doctor as soon as possible if you notice any of the following: burning sensation in the chest rising up to the throat (heartburn); pain on urination, urge to urinate, frequent urination, or blood in the urine; sudden signs of allergic reaction (rash, itching, hives, shortness of breath, wheezing, coughing, swelling of the limbs, face, lips, mouth, tongue or throat). Always read the label and use only as directed. If symptoms continue or you have side effects, see your doctor or healthcare professional. For more information, please contact your healthcare provider or CSL Biotherapies (NZ) Ltd, PO Box 62 590, Central Park, Auckland 1544, Freephone 0800 502 757 or www.cslbiotherapies.co.nz. VESICARE is a registered trademark of Astellas Pharma International. Date of Preparation: October 2009. VESI-068-12/09 DA993PG TAPS CH2477
Website last updated December 2009.
For further information, click on the helpful links below.
International Continence Society
everybody.co.nz – Continence
Consumer Medicine Information
Medicine Data Sheet
Last Updated: 02-12-2012